USA - engelsk - NLM (National Library of Medicine)

sun pharmaceutical industries, inc - sulfamethoxazole (unii: je42381tnv) (sulfamethoxazole - unii:je42381tnv), trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - sulfamethoxazole 800 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of bactrim (sulfamethoxazole and trimethoprim) tablets and other antibacterial drugs, bactrim (sulfamethoxazole and trimethoprim) tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to empiric selection of therapy. urinary tract infections for the treatment of urinary tract infections due to susceptible strains of the following organisms: escherichia coli , klebsiella species, enterobacter species, morganella morganii , proteus mirabilis and proteus vulgaris . it is recommended that initial episodes of uncomplicated urinary tract infections be treated with a single effective antibacterial agent rather than the combination. acute otitis media for the treatment of acute otitis media in pediatric patients due to susceptible strains of streptococcus pneumoniae or haemophilus influenzae when in the judgment of the physician sulfamethoxazole and trimethoprim offers some advantage over the use of other antimicrobial agents. to date, there are limited data on the safety of repeated use of bactrim in pediatric patients under two years of age. bactrim is not indicated for prophylactic or prolonged administration in otitis media at any age. acute exacerbations of chronic bronchitis in adults for the treatment of acute exacerbations of chronic bronchitis due to susceptible strains of streptococcus pneumoniae or haemophilus influenzae when a physician deems that bactrim could offer some advantage over the use of a single antimicrobial agent. shigellosis for the treatment of enteritis caused by susceptible strains of shigella flexneri and shigella sonnei when antibacterial therapy is indicated. pneumocystis jirovecii pneumonia for the treatment of documented pneumocystis jirovecii pneumonia and for prophylaxis against p. jirovecii pneumonia in individuals who are immunosuppressed and considered to be at an increased risk of developing p. jirovecii pneumonia. traveler's diarrhea in adults for the treatment of traveler's diarrhea due to susceptible strains of enterotoxigenic e. coli . bactrim is contraindicated in the following situations: - a known hypersensitivity to trimethoprim or sulfonamides - history of drug-induced immune thrombocytopenia with use of trimethoprim and/or sulfonamides - documented megaloblastic anemia due to folate deficiency - pediatric patients less than 2 months of age - marked hepatic damage - severe renal insufficiency when renal function status cannot be monitored - concomitant administration with dofetilide (see precautions ).

Filippinene - engelsk - FDA (Food And Drug Administration)

superiorvet inc.; distributor: superiorvet inc. - inactivated actinobacillus pleuropneumoniae vaccine (vet.) - suspension for injection (in - inactivated actinobacillus pleuropneumoniae (total bacterial count) 41-1 strain (serotype 1) (seed), shp-1 strain 9serotype 2) (seed), ng-2 strain (serotype 5) (seed)- 1.0x10^9 ~5.0x10^9 cells each; non-toxigenic cytotoxic cytotoxins of actinobacillus pleuropneumoniae (derived from recombinant escherichia coli) rapx i protein (seed), rapx ii protein (seed), rapx iii protein (seed) - 80-120 mcg each

USA - engelsk - NLM (National Library of Medicine)

oxigenesis, inc. - silver (unii: 3m4g523w1g) (silver - unii:3m4g523w1g), glycerin (unii: pdc6a3c0ox) (glycerin - unii:pdc6a3c0ox) - uses relieves and prevents the discomfort and symptoms from: diaper rash, chaffed skin, minor burns and abrasions. stop use and ask a doctor if condition worsens or does not improve in 7 days. directions change wet and solid diapers promptly. cleanse diaper area and dry. apply ointment liberally as often necessary with every diaper change, especially at bedtime.

USA - engelsk - NLM (National Library of Medicine)

oxigenesis, inc - menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a) - purpose external analgesic - for the temporary relief of pain and soreness. - may help distract from pain. - may provide a cooling sensation.

USA - engelsk - NLM (National Library of Medicine)

oxigenesis, inc - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) -

USA - engelsk - NLM (National Library of Medicine)

oxigenesis, inc. - hypochlorous acid (unii: 712k4cdc10) (hypochlorous acid - unii:712k4cdc10), silver (unii: 3m4g523w1g) (silver - unii:3m4g523w1g) - sanitizer, disinfectan eco-friendly, child-friendly, animal friendly, completely safe, alcohol free, chemical free, non-toxic, rinse free, non-sticky, quick drying, a non-irritant and ph balanced.

India - engelsk - Central Drugs Standard Control Organization

renova hc. - moxifloxacin - eye dps - 0.5%w/v - 5ml

Bangladesh - engelsk - DGDA (Directorate General of Drug Administration)

general pharmaceuticals ltd, unit-2 - moxifloxacin - eye drops - 500 mg/100 ml

Bangladesh - engelsk - DGDA (Directorate General of Drug Administration)

general pharmaceuticals ltd, unit-2 - dexamethasone + moxifloxacin - eye drops - 100 mg + 500 mg/100 ml

Bangladesh - engelsk - DGDA (Directorate General of Drug Administration)

general pharmaceuticals ltd, unit-2 - moxifloxacin - eye drops - 5 mg/ml